— Know what they know.
Not Investment Advice

ETTX NASDAQ

Entasis Therapeutics Holdings Inc.
1W: -0.5% 1M: +0.5% 3M: +18.4% 1Y: -11.3% 3Y: -65.5%
$2.19
Last traded 2022-07-08 — delisted
NASDAQ · Healthcare · Biotechnology

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2022-05-24
Earliest Filing
2022-05-24
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named ETTX in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
INVA Innoviva, Inc. acquirer Target company in a merger agreement where Innoviva will acquire all outstanding shares via a tender offer. 2022-05-24 View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms